TNFRSF9 and neoplasm: In murine tumors CD8+CD137+ cells represented up to 5% of tumor-infiltrating CD8 T cells, and TCRs from clonally expanded CD8+CD137+ cells were mostly tumor-reactive (43), suggesting that this population also enriches for tumor-reactive cells.